Abstract
It is understood that colorectal adenomas progress to colonic adenocarcinoma. Adenoma detection rate (ADR) at endoscopy has been used as a key performance indicator at endoscopy and is inversely associated with diagnosis of interval colorectal cancer. As most endoscopy reporting systems do not routinely incorporate histological assessment, ADR reporting is a cumbersome task. Polyp Detection Rate (PDR) has therefore been adopted as a surrogate marker for ADR. A prospectively maintained database of colonoscopies performed between July 2015 and July 2017 was analysed. This was cross referenced with a histological database. Statistical analysis was performed using IBM SPSS, version 24. Inferential procedures employed included the Pearson’s correlation coefficient (r) and Binomial logistic regression. Of 2964 procedures performed by 8 endoscopists, overall PDR was 27% and ADR was 19%. The PDR, ADR, adenoma to polyp detection rate quotient (APDRQ) and estimated ADR (PDR x APDRQ group average = 0.72) was calculated for each individual. There was a strong positive linear correlation between PDR and ADR,r(8) = 0.734, p = 0.038 and between PDR and estimated ADR, r(8) = 0.998, p < 0.001. Adenoma detection rate strongly correlated with estimated ADR, r(8) = 0.720, p = 0.044. With the exclusion of a moderate outlier, these correlations increased in both strength and significance. There was a stronger correlation between PDR and ADR,r(7) = 0.921, p = 0.003 and between ADR and estimated ADR, r(7) = 0.928, p = 0.003.
Highlights
It is understood that colorectal adenomas progress to colonic adenocarcinoma
While the specialist bodies BGS, Joint Advisory Group on GI Endoscopy (JAG) and ACPGBI support the use of Polyp Detection Rate (PDR) as an estimate of Adenoma detection rate (ADR), this is based on the prerequisite that PDR be validated as a marker on an individual unit level[5]
We have demonstrated that PDR may be used as a reliable indicator of ADR within an endoscopy unit
Summary
It is understood that colorectal adenomas progress to colonic adenocarcinoma. Adenoma detection rate (ADR) at endoscopy has been used as a key performance indicator at endoscopy and is inversely associated with diagnosis of interval colorectal cancer. The British Society of Gastroenterology (BSG), the UK Joint Advisory Group on GI Endoscopy (JAG), and the Association of Coloproctology of Great Britain and Ireland (ACPGBI) have established a working group to develop key performance indicators for the delivery of colonoscopy as a measure of quality assurance in the United Kingdom and Ireland[5]. This working group has suggested a minimum standard for adenoma detection rate at 15% with an aspirational ADR of 20%5.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.